Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 507,144 | 79,449 | 77,123 | 218,375 | 39,853 |
| Marketable Securities | 962,553 | 335,907 | 387,174 | 187,851 | 138,478 |
| Other current assets | 5,674 | 0 | 0 | 0 | 0 |
| TOTAL | $1,495,655 | $430,031 | $480,836 | $409,607 | $181,955 |
| Non-Current Assets | |||||
| PPE Net | 40,846 | 46,732 | 25,162 | 14,923 | 15,262 |
| Investments And Advances | 32,699 | 39,886 | 147,881 | 60,750 | 72,580 |
| Other Non-Current Assets | 35,080 | 36,582 | 8,105 | 1,441 | 1,270 |
| TOTAL | $108,625 | $123,200 | $181,148 | $77,114 | $89,112 |
| Total Assets | $1,604,280 | $553,231 | $661,984 | $486,721 | $271,067 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,071 | 2,590 | 1,891 | 2,716 | 1,963 |
| Accrued Expenses | 47,145 | N/A | N/A | 5,364 | 3,850 |
| Other current liabilities | 23,483 | 42,754 | 30,895 | 6,084 | 3,293 |
| TOTAL | $71,699 | $45,344 | $32,786 | $14,164 | $9,106 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 382,050 | 112,997 | 82,353 | 6,761 | 7,442 |
| TOTAL | $382,050 | $112,997 | $82,353 | $6,761 | $7,442 |
| Total Liabilities | $453,749 | $158,341 | $115,139 | $20,925 | $16,548 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 120,984 | 105,423 | 95,289 | N/A | N/A |
| Common Shares | 1,531 | 1,288 | 1,273 | 1,201 | 344 |
| Retained earnings | -354,415 | -425,551 | -227,937 | -191,697 | -103,512 |
| Other shareholders' equity | -245 | 350 | -649 | -368 | 348,300 |
| TOTAL | $1,150,531 | $394,890 | $546,845 | $465,796 | $254,519 |
| Total Liabilities And Equity | $1,604,280 | $553,231 | $661,984 | $486,721 | $271,067 |